
November 4, 2017 - By Michael Collier
Congress Asset Management Company decreased its stake in Starbucks Corp (SBUX) by 3.61% based on its latest 2017Q2 regulatory filing with the SEC. Congress Asset Management Company sold 7,541 shares as the company’s stock rose 6.99% with the market. The institutional investor held 201,177 shares of the restaurants company at the end of 2017Q2, valued at $11.73 million, down from 208,718 at the end of the previous reported quarter. Congress Asset Management Company who had been investing in Starbucks Corp for a number of months, seems to be less bullish one the $80.90 billion market cap company. The stock increased 2.11% or $1.16 on November 3, reaching $56.03. About 28.77 million shares traded or 236.49% up from the average. Starbucks Corporation (NASDAQ:SBUX) has risen 12.48% since November 4, 2016 and is uptrending. It has underperformed by 4.22% the S&P500.Bain Capital decreased its stake in Astrazeneca Plc (Call) (AZN) by 75% based on its latest 2017Q2 regulatory filing with the SEC. Brookside Capital Management Llc sold 30,000 shares as the company’s stock rose 16.26% with the market. The hedge fund run by Bain Capital held 10,000 shares of the major pharmaceuticals company at the end of 2017Q2, valued at $1.45M, down from 40,000 at the end of the previous reported quarter. Brookside Capital Management Llc who had been investing in Astrazeneca Plc (Call) for a number of months, seems to be less bullish one the $85.62B market cap company. The stock increased 1.11% or $0.38 on November 3, reaching $34.48. About 2.92M shares traded. AstraZeneca plc (ADR) (NYSE:AZN) has risen 19.45% since November 4, 2016 and is uptrending. It has outperformed by 2.75% the S&P500.More recent AstraZeneca plc (ADR) (NYSE:AZN) news were published by: Investorplace.com which released: “AstraZeneca plc (ADR) (AZN) Shares Soar on Lung Cancer Drug Success” on May 12, 2017. Also Investorplace.com published the news titled: “AstraZeneca plc (ADR) (AZN) Stock Tanks on Lung Cancer Drug Disappointment” on July 27, 2017. Investorplace.com‘s news article titled: “Why AstraZeneca plc (ADR) (AZN), Advanced Micro Devices, Inc. (AMD) and Spirit …” with publication date: July 27, 2017 was also an interesting one.Among 24 analysts covering AstraZeneca plc (ADR) (NYSE:AZN), 14 have Buy rating, 0 Sell and 10 Hold. Therefore 58% are positive. AstraZeneca plc (ADR) had 39 analyst reports since July 31, 2015 according to SRatingsIntel. The rating was downgraded by Credit Suisse on Tuesday, October 20 to “Underperform”. The rating was upgraded by Credit Suisse to “Buy” on Monday, October 16. The rating was downgraded by Nordea to “Hold” on Monday, November 2. The stock of AstraZeneca plc (ADR) (NYSE:AZN) has “Buy” rating given on Monday, August 29 by Argus Research. The firm has “Equal-Weight” rating by Morgan Stanley given on Friday, July 28. The firm has “Market Perform” rating by Leerink Swann given on Monday, May 2. Piperjaffray initiated AstraZeneca plc (ADR) (NYSE:AZN) on Friday, September 23 with “Overweight” rating. The firm earned “Buy” rating on Wednesday, August 9 by Piper Jaffray. Bryan Garnier & Cie upgraded AstraZeneca plc (ADR) (NYSE:AZN) on Friday, September 18 to “Buy” rating. The company was maintained on Wednesday, October 18 by Citigroup.Brookside Capital Management Llc, which manages about $1.66 billion US Long portfolio, upped its stake in Ball Corp (NYSE:BLL) by 1.02 million shares to 1.65M shares, valued at $69.53M in 2017Q2, according to the filing. It also increased its holding in Galapagos Nv by 16,536 shares in the quarter, for a total of 71,136 shares, and has risen its stake in Immune Design Corp (NASDAQ:IMDZ). Analysts await AstraZeneca plc (ADR) (NYSE:AZN) to report earnings on November, 9. They expect $0.50 earnings per share, down 62.12% or $0.82 from last year’s $1.32 per share. AZN’s profit will be $1.24B for 17.24 P/E if the $0.50 EPS becomes a reality. After $0.87 actual earnings per share reported by AstraZeneca plc (ADR) for the previous quarter, Wall Street now forecasts -42.53% negative EPS growth. Since May 3, 2017, it had 0 buys, and 3 selling transactions for $8.07 million activity. 114,826 shares valued at $6.83M were sold by BURROWS CLIFFORD on Thursday, May 18.More notable recent Starbucks Corporation (NASDAQ:SBUX) news were published by: Seekingalpha.com which released: “Starbucks Redux” on October 30, 2017, also Seekingalpha.com with their article: “Starbucks lower after earnings” published on November 02, 2017, Nasdaq.com published: “Earnings Reaction History: Starbucks Corporation, 50.0% Follow-Through …” on November 02, 2017. More interesting news about Starbucks Corporation (NASDAQ:SBUX) were released by: Zacks.com and their article: “Starbucks (SBUX) Sink As Q4 Earnings & Revenues Fall Short Of Expectations” published on November 02, 2017 as well as Investorplace.com‘s news article titled: “Avoid Starbucks Corporation (SBUX) Stock Before Earnings” with publication date: October 31, 2017.Among 35 analysts covering Starbucks Corporation (NASDAQ:SBUX), 25 have Buy rating, 0 Sell and 10 Hold. Therefore 71% are positive. Starbucks Corporation had 72 analyst reports since July 28, 2015 according to SRatingsIntel. The firm has “Buy” rating by Piper Jaffray given on Friday, July 28. RBC Capital Markets maintained the stock with “Buy” rating in Tuesday, June 13 report. The firm has “Buy” rating given on Wednesday, May 4 by Goldman Sachs. The rating was maintained by CLSA on Wednesday, September 28 with “Buy”. On Wednesday, July 12 the stock rating was maintained by RBC Capital Markets with “Buy”. Zacks downgraded the stock to “Hold” rating in Thursday, September 3 report. Wedbush maintained the stock with “Outperform” rating in Monday, March 13 report. On Friday, March 18 the stock rating was reinitiated by Stifel Nicolaus with “Hold”. The rating was maintained by BTIG Research with “Buy” on Friday, July 22. The stock of Starbucks Corporation (NASDAQ:SBUX) earned “Hold” rating by Stifel Nicolaus on Friday, July 28.Investors sentiment increased to 1.21 in Q2 2017. Its up 0.34, from 0.87 in 2017Q1. It is positive, as 68 investors sold SBUX shares while 409 reduced holdings. 104 funds opened positions while 473 raised stakes. 988.30 million shares or 1.42% more from 974.49 million shares in 2017Q1 were reported. Johnson Counsel stated it has 116,813 shares or 0.19% of all its holdings. Dubuque Bank Trust Com holds 1.04% of its portfolio in Starbucks Corporation (NASDAQ:SBUX) for 82,023 shares. Shelton Capital Mngmt holds 0.52% or 125,363 shares in its portfolio. Ohio-based Mai Cap has invested 0.08% in Starbucks Corporation (NASDAQ:SBUX). D L Carlson Invest Gp owns 1.32% invested in Starbucks Corporation (NASDAQ:SBUX) for 77,147 shares. Pinebridge Investments Ltd Partnership invested in 0.01% or 7,003 shares. Associated Banc has invested 0.39% in Starbucks Corporation (NASDAQ:SBUX). Baldwin Brothers Ma has invested 0.12% in Starbucks Corporation (NASDAQ:SBUX). Webster Commercial Bank N A holds 0% of its portfolio in Starbucks Corporation (NASDAQ:SBUX) for 350 shares. Highlander Cap Management Lc holds 500 shares. Peloton Wealth Strategists invested in 2.65% or 58,750 shares. Raymond James Trust Na has 25,927 shares for 0.11% of their portfolio. Evercore Wealth Management Limited Co stated it has 27,795 shares or 0.06% of all its holdings. Bender Robert & Assocs holds 72,448 shares or 2.59% of its portfolio. 24,000 were accumulated by Nexus Incorporated.Congress Asset Management Company, which manages about $7.47 billion and $5.59 billion US Long portfolio, upped its stake in Scripps Networks Inter (NYSE:SNI) by 150,016 shares to 956,213 shares, valued at $65.32 million in 2017Q2, according to the filing. It also increased its holding in Middleby Corp (NASDAQ:MIDD) by 64,323 shares in the quarter, for a total of 539,471 shares, and has risen its stake in Jack Henry & Associates (NASDAQ:JKHY). Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.



(adsbygoogle = window.adsbygoogle || []).push({});
TRADE IDEAS REVIEW – IS THIS THE BEST STOCK SCANNER?

Trade Ideas is arguably one of the top scanning tools available on the market right

Trade Ideas Pro helps traders find the best setups in the market right NOW

Scottrade and E*TRADE license Trade Ideas proprietary technology for their premium trading platforms. We have fully automated trading available through Lightspeed and Interactive Brokers.Trade Ideas is the BEST Tool for Scanning. I would be LOST without Trade ideas. Ross Cameron – Warrior Trading